INTERNATIONAL PATENT: APTACURE THERAPEUTICS LIMITED, 安沛治疗有限公司 FILES APPLICATION FOR "APTAMER CONJUGATE FOR TARGETED DEGRADATION OF SCLEROSTIN"

GENEVA, May 11 -- APTACURE THERAPEUTICS LIMITED (M13, 1/F, Unit 101-103, Building 15 Of Hong Kong Science Park, No. 15 Science Park West Avenue, Pak Shek Kok, New TerritoriesHong Kong), 安沛治疗有限公司 (中国香港特别行政区新界,科学园西大街,科学园15号楼,101-103单元,1楼,M13) filed a patent application (PCT/CN2024/129258) for "APTAMER CONJUGATE FOR TARGETED DEGRADATION OF SCLEROSTIN" on Nov 01, 2024. With publication no. WO/2025/092956, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was ...